Osaic Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10
Closed -$350 7629
2024
Q3
$350 Buy
+10
New +$424 ﹤0.01% 7077
2022
Q2
Sell
-4
Closed -$6K 7593
2022
Q1
$6K Buy
+4
New +$467 ﹤0.01% 6419

Other funds holding TNDM

Osaic Holdings's TNDM Position: Q2 2026 in Review

Osaic Holdings increased its Tandem Diabetes Care (TNDM) stake by 20% in Q2 2026, buying an estimated $9.13K and bringing the position to 3,111 shares worth $46.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5538.

Osaic Holdings first reported a position in TNDM in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.1M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Osaic Holdings held 3,111 shares of Tandem Diabetes Care worth $46.9K as of Q2 2026.
  • Osaic Holdings bought 523 Tandem Diabetes Care shares in Q2 2026, an estimated $9.13K.
  • Tandem Diabetes Care made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5538 holding.
  • Osaic Holdings first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Tandem Diabetes Care position peaked at $2.1M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.